WebPrimary Endpoint: 1-Year Binary Primary Patency rate of 83.2% in the Eluvia arm vs. 74.3% in the Bare-Metal Stenting arm (p-value = 0.0077). 3. IMPERIAL Trial: A global randomized controlled multi-center trial with 2:1 randomization of the Eluvia™ Drug-Eluting Stent against Cook Medical’s Zilver™ PTX™ Stent, single-blind, non ... WebRavish Sachar's 35 research works with 1,059 citations and 1,384 reads, including: PERFORMANCE 1 study: Novel carotid stent system with integrated post-dilation balloon …
1-Year Results From the RANGER II SFA Randomized Trial of the …
WebNov 2, 2024 · November 2, 2024—Boston Scientific announced it has received FDA approval for the Ranger drug-coated balloon (DCB), which was developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA). The FDA approval is based on results from the RANGER II SFA ... WebJul 7, 2010 · Dr. Ravish Sachar, MD, is a Peripheral Vascular Disease specialist in Wake Forest, North Carolina. He attended and graduated from University Of Southern California … phoneboy guitar tabs
Ravish Sachar, MD - Internist in Raleigh, NC MD.com
WebRavish Sachar, MD. Dr. Ravish Sachar is the physician-in-chief of the UNC-REX Heart and Vascular Service Line in Raleigh, NC. He completed his residency in Internal Medicine at … WebMay 24, 2024 · Sachar has served in the last 24 months as a consultant, advisory board member for, and received compensation for, educational programs from Boston Scientific … WebDr. Ravish Sachar, M.D., FACC is the Founder of Contego Medical, LLC, and serves as its Chief Executive Officer. Dr. Sachar serves as Physician-in-chief of the UNC Rex Heart & … phoneboy lyrics